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Abstract
To deepen our understanding of early rectal transmission of HIV-1, we studied virus-host 
interactions in the rectal mucosa using simian immunodeficiency virus (SIV)-Indian rhesus 
macaque model and mRNA deep sequencing. We found that rectal mucosa actively responded to 
SIV as early as 3 days post-rectal inoculation (dpi) and mobilized more robust responses at 6 and 
10 dpi. Our results suggests that the failure of the host to contain virus replication at the portal of 
entry is attributable to both a high-level expression of lymphocyte chemoattractant, 
proinflammatory and immune activation genes, which can recruit and activate viral susceptible 
target cells into mucosa; and a high-level expression of SIV accessory genes, which are known to 
be able to counter and evade host restriction factors and innate immune responses. This study 
provides new insights into the mechanism of rectal transmission.
Keywords
Simian Immunodeficiency Virus (SIV); rectal transmission; mucosal response; mRNA-seq
*Corresponding author. qli@unl.edu. 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Virology. Author manuscript; available in PMC 2016 March 27.
Published in final edited form as:
Virology. 2014 September ; 464-465: 406–414. doi:10.1016/j.virol.2014.07.010.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Introduction
Anal-rectal mucosa is an important portal for HIV-1 entry in both men and women, and 
especially among men who have sex with men (MSM). MSM have a higher risk of 
contracting HIV-1 infection in both developed and developing countries than any other 
population (CDC, 2011; van Griensven et al., 2010). It has been estimated that one-half to 
two-thirds of MSM participate in anal intercourse (Mansergh et al., 2001; McGowan, 2008), 
and up to 40% of heterosexual men and 35% of women engage in anal intercourse (Kingsley 
et al., 1987; van Griensven et al., 2010). While the single columnar epithelial mucosal 
barrier and abundant HIV-1-susceptible target cells in the rectum may explain the increased 
rate of acquisition, the actual mechanisms have not been determined and the current 
knowledge about the earliest virus-host interactions in anorectal transmission is limited. It 
has been demonstrated that both lamina propria and epithelial cells of rhesus small intestines 
at three weeks post SIV infection have robust transcriptional responses (Mohan et al., 2012, 
2013), however, the host responses in days post infection via rectal route, especially at the 
portal of entry, remain unknown. To better understand the earliest events of HIV-1 rectal 
transmission, we studied early virus-host interactions in rectal mucosa of rhesus macaques 
intra-rectally inoculated with simian immunodeficiency virus (SIV), the best available 
model of human rectal transmission of HIV-1 (Keele et al., 2009). Our study revealed 
profound changes in rectal mucosal gene expression as early as 3 days post-inoculation (dpi) 
using next-generation RNA sequencing (mRNA-seq), a time point before systemic viral 
dissemination, as compared with uninfected macaques. Interestingly at 3 dpi, chemokine 
CCL13/MCP-4 and CCL20/MIP-3α genes, which are well-known chemoattractants for T 
cells, monocytes and plasmacytoid dendritic cells, were up-regulated. At 6 and 10 dpi, a 
greater number of genes were significantly altered in expression, including 
proinflammatory, immune activation, chemoattractant for lymphocytes, and interferon-
stimulated genes (ISGs) targeting various steps of the viral replication life cycle. Despite the 
strong mucosal anti-viral responses, the virus still subdued the host. Our data suggest that 
the key tactic the virus used to evade the mucosal host antiviral responses may be through 
high-level expression of SIV accessory genes and inducing chemoattractant, 
proinflammatory as well as immune activation genes. Together, this first comprehensive 
genome wide study of early virus-host interaction in rectum provides new insights into the 
mechanism of rectal transmission and identifies potential targets for future studies
Results
To elucidate the virus-host interaction in rectal mucosae during early rectal SIV 
transmission, mRNA-seq was used to simultaneously measure host and virus gene 
expression. Host genes with differential expression (adjusted p-value < 0.05, fold change > 
2) were identified (Supplemental Table 1) and used for analysis. At 3 dpi, while SIV viral 
RNAs were detectable in the rectum by both quantitative RT-PCR and in situ hybridization 
(ISH), but not in distal lymph nodes and blood (manuscript in preparation), SIV viral RNAs 
were not detected in the rectum by RNA-seq, indicating SIV was only replicating locally 
and at low-level in this time point and RNA-seq is less sensitive to detect low-levels of viral 
RNA than RT-PCR and ISH. At 6 and 10 dpi, SIV vRNA was detected in rectum, blood and 
distal lymph nodes of all the rhesus macaques by RT-PCR and ISH (manuscript in 
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preparation); furthermore SIV viral RNAs in the rectum were also detected by RNA-seq, 
and the read counts at 10 dpi are higher than 6 dpi (Fig. 5). The mRNA-seq analyses showed 
that host rectal mucosa responded to SIV as early as 3 dpi, with 116 (66.7%) genes up-
regulated and 58 (33.3%) genes down-regulated (Fig. 1A). At day 6, there were 585 
differentially expressed genes (DEGs), among which 320 (54.7%) were up-regulated and 
265 (45.3%) were down-regulated. The largest number of DEGs occurred at 10 dpi, with 
943 (65.1%) up-regulated and 506 (34.9%) down-regulated. Both unique and shared DEGs 
between each time point were observed, with 47 (3 dpi), 310 (6 dpi) and 1,155 (10 dpi) 
unique genes (Fig. 1B and supplementary Fig. 1). Notably, there was a clear preponderance 
of unique and shared DEGs during the course of infection, reflecting the enhanced host’s 
responses to infection over time. To better understand the biological functions of the altered 
genes and their associated signaling pathways in the context of early rectal SIV 
transmission, DEGs were further classified (Fig. 2). There were 37.9% (66/174), 26.8% 
(157/585) and 46.7% (677/1449) of DEGs classifiable at 3, 6 and 10 dpi, respectively.
Host rectal mucosal responses at 3 dpi
As early as 3 dpi, the rectal mucosae of SIV-infected macaques exhibited dramatic changes 
in gene expression as compared with uninfected control macaques (Fig. 2A). The DEGs 
encoded proteins involved in apoptosis (CIDEC and TNFRSF12A), cell adhesion (MSLN 
and THBS1), gene expression (FOSB and NR4A1), inflammation, cell metabolism and 
maintenance. Interestingly, chemokine CCL13/MCP-4 and CCL20/MIP-3α, which are well-
known chemoattractants for T cells, monocytes and plasmacytoid dendritic cells, were up-
regulated at 3 dpi. In addition to the genes encoding immune cell attractants, immune 
activation genes (NOS2, CD1D, CNTFR and FDCSP) were also up-regulated. Notably, 
FDCSP, which encodes a secreted protein in activated follicular dendritic cells (FDCs), was 
further up-regulated 3.7- and 10.7-fold at 6 dpi and 10 dpi, respectively, suggesting 
activation and proliferation of FDCs in rectal tertiary follicular aggregates.
Genes involved in cell metabolism and maintenance accounted for most of the DEGs at 3 
dpi. These genes encode for proteins involved in the transportation of water (AQP8), iron 
(NKAIN4), chloride (CLIC6), sodium (SCNN1G) and other solutes (SLC6A20, SLC9A3, 
SLC26A2 and SLC6A14) across the cell membrane and protein modification (SGK1). 
Several DEGs encode for proteins involved in metabolism of lipids (MOGAT2, CYP1A1, 
THRSP, SCD, HMGCS2, LPL, ACSL1, FASN, ADIPOQ), carbohydrates (GCK, 
B4GALNT2, PFKFB1), proteins (MEP1B, MEP1A, KLK15, GZMA), alcohol (ADH4, 
ADH1B) and others (CDO1, FMO3, MOSC1, GPD1).
More active rectal responses at 6 and 10 dpi
Consistent with the elevated viral load and systemic dissemination of SIV at 6 and 10 dpi, 
there was significantly increased number of DEGs as compared with 3 dpi. Although the 
genes involved in cell metabolisms and maintenance still accounted for most of the DEGs, 
we will mainly discuss the immunity-related genes below.
The activation of pattern recognition receptors—Innate immune responses are 
triggered by host’s pattern recognition receptors (PRRs) bound to pathogen-associated 
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molecular patterns (PAMPs). Four PRR genes (RIG-I, LGP2, MDA5 and DDX60) were up-
regulated at 6 dpi, of which RIG-1 and MDA5 were up-regulated 7- and 4.6-fold, 
respectively, and LGP2, a protein homologous to RIG-I and MDA5, was up-regulated 3.7-
fold (Fig. 2B and Fig. 3). Surprisingly, at 10 dpi, in addition to PRRs for virus recognition 
(RIG-I, MDA5, LGP2, TLR3 and TLR7), PRRs recognizing bacterial patterns (MARCO, 
NOD2 and TLR2) were also up-regulated (Fig. 2C and Fig. 3). In addition to viral RNA 
recognition, genes involved in viral DNA recognition (DAI, IFI16 and AIM2) were up-
regulated (Fig. 2C and Fig. 3), indicating activation of viral DNA pattern recognition by the 
presence of SIV DNA in rectal mucosa.
Antiviral and IFN signaling activation—Among the DEGs, IFN signaling activation 
stood out at both 6 and 10 dpi (Fig. 2B and 2C), most of which were IFN-stimulated genes 
(ISGs) with anti-viral activities. To better understand the functions of these ISGs, we 
illustrated them in the context of IFN signaling pathways (Fig. 3). At 10 dpi, which was 
around the peak of viral replication in the rectum, the number of DEGs and the magnitude of 
up-regulation were significantly increased as compared with 6 dpi.
Interestingly, the genes of anti-viral ISGs were significantly up-regulated, targeting almost 
every step of virus replication life cycle, i.e., inhibition of viral entry (IFITM1 and IFITM3); 
blockade of viral disassembly (TRIM5); introduction of hypermutations (APOBEC3A, 
APOBEC3C, APOBEC3D, APOBEC3F and APOBEC3G); blockade of viral DNA 
synthesis (SAMHD1 and MOV10); inhibition of viral transcription (MX1, MX2, PML and 
SP100); degradation of mRNA (OAS1, OAS2, OAS3 and OASL); inhibition of protein 
translation (SLFN13, SLFN14, PKR and IFIT protein family); blockade of viral Gag protein 
trafficking (TRIM22); blockade of viral assembly (HERC5 and HERC6); and blockade of 
viral release (ISG15, BST2/tetherin and viperin). In addition to direct inhibition of the virus, 
several ISGs involved in viral suppression through antigen presentation (PSMB8) and 
unknown mechanisms (IFI44L, IFI6, IFI35, TNFSF10 and DDIT4) were also up-regulated.
Inflammation, immune activation and cell trafficking—In addition to active IFN 
responses, the expression of genes related to the mucosal proinflammatory responses, 
immune activation and immune cell trafficking was also significantly up-regulated (Fig. 2). 
At 6 and 10 dpi, CXCL11, the major ligand of CXCR3, was the most up-regulated cytokine, 
with greater than 100-fold up-regulation at 10 dpi. Other CXCR3 ligands (CXCL10 and 
CXCL9) were among the most up-regulated DEGs. DEGs encoding CCR5 ligands (CCL3/
MIP-1α, CCL3L1, CCL5/RANTES and CCL8/MCP-2) were also up-regulated. Other 
important chemoattractant genes for T cells (CXCL1, CCR1, CCL13 and CCL8), myeloid 
dendritic cells (CCL19 and CCL21), monocytes (CCR1, CCL2, CCL13 and CCL8), and 
neutrophils (CXCL1, FPR3) were significantly up-regulated. Moreover, adhesion/homing 
receptor L-selectin (SELL/CD62L) and receptor CCR7, which control the migration of 
memory T cells to inflamed tissues, were up-regulated, suggesting the augmentation of T 
cell migration to the rectal mucosa. Notably, among the DEGs, IL18 was down-regulated, 
and IL18 inhibitor (IL18BP) and the immune suppressive molecule CD274/PD-L1 were up-
regulated.
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Complement and Fc receptor activation—In line with increased inflammatory 
responses and immune activation, complement and Fc receptor genes (PTX3 and CD93/
C1QR) were altered in expression at 6 dpi, and many more genes in this category were 
altered in expression at 10 dpi, such as components of the complement classical pathway 
(C1R, C1S, PTX3, CLEC1A), lectin pathway (CLEC1A, FCN1, FCN2), alternative pathway 
(CFB), or common factors shared by these pathways (C3 and C4), and Fc receptors for IgE 
(FCER1A) and IgG (FCGR1, FCGR3). All of the above DEGs were up-regulated except 
FCER1A (-2.5-fold).
Antigen presentation—Interestingly, DEGs highlight the activation of MHC class I 
antigen presentation. TAP1, TAP2, PSMB8/LMP7/β5i and PSMB9/LMP2/β1i, members of 
the antigen-processing machinery (APM), were up-regulated. PSMB8 and PSMB9, both 
induced by IFN-γ, are integral components of the immunoproteasome where peptides are 
generated and transferred to the endoplasmic reticulum to form peptide-MHC class I 
complexes. Consistent with enhanced peptide processing and transportation, MHC class I α-
chain (MAMU-A, MAMU-AG, MAMU-B, MAMU-E, MAMU-F, MAMU-I) and β-chain 
(B2M) genes were also up-regulated.
Mapping the DEGs to rectal mucosa in vivo
To validate the elevated expression of DEGs and determine their spatial distribution in the 
rectum, we performed immunohistochemical staining (IHCS) of IFITM3, a recently 
identified anti-viral factor, and Mx1, one of the most up-regulated genes during early SIV 
infection. Consistent with the mRNA-seq data, IFITM3 and Mx1 proteins were significantly 
elevated in the lamina propria at 6 dpi (13- and 25-fold, respectively) and 10 dpi (28- and 
63-fold, respectively) (Fig. 4) as compared with the rectal mucosa of SIV-uninfected 
macaques.
SIV genome-wide expression
To better understand the genome-wide transcription pattern of SIV in vivo in early rectal 
infection, we mapped virus mRNA-seq reads to the SIVmac251 reference genome and 
calculated the read coverage at each nucleotide position. There was no significant difference 
between 3 dpi and the uninfected control for read mapping, indicating that mRNA-seq 
approach is less sensitive for detecting viral replication than qRT-PCR and ISH. As shown 
in Fig. 5, SIV mRNA was readily detectable at 6 dpi and increased further at 10 dpi using 
mRNA-seq, which is consistent with our qRT-PCR and ISH data (unpublished data). The 
mRNA levels of different SIV genes were not equivalent: genes encoding Env and accessory 
proteins (Vif, Vpu, Vpr, Vpx and Nef) were much higher than those of Gag and Pol in 
expression. For read coverage, there were larger peaks and valleys in the Env and Nef than 
the Gag and Pol regions. While the peaks reflected high levels of Env and Nef mRNAs, the 
valleys indicated that, in the transmitted/founder viruses in rhesus rectal mucosa, there were 
sequence polymorphism in env and nef genes, mismatched to SIVmac251 reference genome.
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Discussion
The anorectal mucosa is a major entry site in HIV-1 transmission, especially among men 
who have sex with men (MSM). To shed light on the mechanism of HIV-1 rectal 
transmission, we employed next-generation mRNA-seq and studied virus-host interactions 
in the rectal mucosa during very early infection.
We found that there are robust host rectal mucosal responses to early rectal SIV 
transmission. At 3 dpi when SIV replication was still restricted within the portal of entry and 
before systemic dissemination, inflammation-related genes (CCL13, CCL20, CD1D, 
CNTFR, FDCSP, and NOS2) were significantly up-regulated. CCL13 is known for 
chemotaxis of monocytes, T cells, natural killer (NK) cells and immature dendritic cells, and 
CCL20 for T cells, B cells and immature dendritic cells. Strikingly, we found that the 
chemoattractant genes CCL13 and CCL20 were up-regulated at both 3 and 6 dpi. Up-
regulated CCL20 and CCL13 gene expression in the rectal mucosa suggests that these 
chemokines may play a key role in recruiting virus-susceptible target cells to the rectal 
mucosa in the very early stage of transmission.
The early immune responses to rectal SIV exposure are initiated by PRRs that recognize 
SIV PAMPs. Viral RNA pattern recognition genes (RIG-I, LGP2, MDA5, DDX60, TLR3, 
and TLR7) were up-regulated at 6 and 10 dpi. RIG-I is a key PRR that triggers IFN 
expression after detection of double-stranded RNA with a 5′ triphosphate (5′ppp-dsRNA) 
(Kowalinski et al., 2011). A recent report suggested that LGP2 acts upstream of RIG-I and 
MDA5 to facilitate their recognition of viral dsRNA (Satoh et al., 2010). DDX60 was 
recently reported to be an antiviral factor that interacts with RIG-I, MDA5 and LGP2 and 
regulates RIG-I- and MDA5-mediated type I IFN activation after viral infection (Miyashita 
et al., 2011). Moreover, genes involved in viral DNA recognition (DAI, IFI16 and AIM2) 
were significantly up-regulated at 10 dpi, reflecting the presence of viral DNA in the 
cytoplasm after reverse transcription of SIV genomes, and previous studies showed that the 
presence of DNA in cytoplasm is a danger signal and can trigger defense responses in 
eukaryotic cells (Barbalat et al., 2011; Thompson et al., 2011). Surprisingly, in addition to 
recognition of viruses, receptors recognizing bacteria (MARCO, NOD2 and TLR2) were 
also up-regulated at 10 dpi, which suggests that the rectal mucosal barrier may be 
compromised, allowing bacteria and/or their products cross over. This speculation is 
consistent with our previous finding of increased intestinal epithelial cell apoptosis during 
early SIV infection (Li et al., 2008).
Our results revealed that after sensing PAMPs, the host’s rectal mucosa mounted two major 
responses: 1) activation of IFN signaling and antiviral responses; and 2) inflammation, cell 
trafficking and immune activation. As shown in Fig. 3, the IFN signaling pathway (STAT1, 
STAT2, SOCS1, SOCS3, IFN-α, IFN-γ, IRF1 and IRF7) was significantly activated, and 
antiviral IFN-stimulated genes (ISGs) were induced at both 6 and 10 dpi. IRF1 plays a 
crucial role in regulating MAVS-dependent signaling from peroxisomes (Dixit et al., 2010) 
and induces the expression of ISGs in the absence of IFN signaling, thereby demonstrating 
broad-spectrum anti-viral activity (Schoggins et al., 2011). IRF7 can induce the expression 
of ISGs in the absence of IFN; therefore, the cell can produce rapid ISG expression before 
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IFN is produced (Schmid et al., 2010), which may explain the high levels of ISGs as early as 
6 days after SIV infection. Suppressor of cytokine signaling (SOCS) genes, which 
negatively regulate type I IFN signaling, were also up-regulated. It has been demonstrated 
that HIV-1 can exploit this mechanism by inducing SOCS3 expression in macrophages, 
resulting in the failure of IFN-β to suppress viral replication (Akhtar et al., 2010). Cytosolic 
DNAs are sensed, triggering IFN-β expression through STING (Barber, 2011), which was 
also up-regulated at 10 dpi.
As shown in Fig. 3, The products of up-regulated ISGs possess broad antiviral activities 
targeting each step of the viral life cycle, which we will discuss in categories based on their 
mechanisms: 1) Inhibition of viral entry. IFITM1 and IFITM3 were up-regulated. It is now 
clear that IFITM1, 2 and 3 have anti-influenza activity (Brass et al., 2009), and a recent 
study showed that IFITM3 inhibits HIV-1 replication in vitro (Schoggins et al., 2011); 2) 
Blocking of virus disassembly. TRIM5 was up-regulated. TRIM5 can inhibit HIV/SIV 
replication by prematurely accelerating viral capsid disassembly (Song et al., 2005; Stremlau 
et al., 2006). In addition to disruption of viral disassembly, binding of TRIM5 to the HIV-1 
capsid catalyzes the synthesis of free ubiquitin chains, leading to AP-1 and NF-κB 
activation (Iwasaki, 2012); 3) Hypermutation of viral genomes. Many apolipoprotein B 
editing catalytic subunit-like 3 family (APOBEC3) genes (A, C, D, F, G and H), which have 
cytidine deaminase (CDA) domains and can induce G-to-A hypermutations in viral DNA 
during reverse transcription, thereby impairing virus infectivity, were significantly up-
regulated at 10 dpi (Bishop et al., 2004). APOBEC3G and APOBEC3F restrict the 
replication of HIV-1 by introducing hypermutations in the viral genome (Zheng et al., 
2004). APOBEC3C is an SIV inhibitor (Yu et al., 2004) and was the most up-regulated (6-
fold) member of the APOBEC3 family at 10 dpi. A recent study showed that APOBEC3A 
inhibits early phases of HIV-1 infection by decreasing viral DNA accumulation (Berger et 
al., 2011); 4) Blocking of reverse transcription. SAM domain HD domain-containing protein 
1 (SAMHD1) can block reverse transcription of HIV-1 by depleting the intracellular pool of 
deoxynucleoside triphosphates (dNTPs) (Lahouassa et al., 2012). MOV10 can be packaged 
into HIV-1 virions and inhibit reverse transcription after viral entry into host cells (Abudu et 
al., 2012); 5) Inhibition of viral transcription. Mx1, Mx2, PML and Sp100 were up-
regulated. After assembly into multimers, GTPases Mx1 and Mx2 inhibit transcription and 
interfere with viral particle assembly. Sp100 is a major component of nuclear domain 10 
(ND10), which harbors multiple functions, including viral inhibition by transcriptional 
repression (Tavalai and Stamminger, 2009); 6) Degradation of viral RNA. OAS1, OAS2, 
OAS3 and OASL, which can synthesize oligo-A, in turn binding and activating RNase L 
and leading to mRNA degradation, were significantly up-regulated (Ishibashi et al., 2010); 
7) Inhibition of translation. PKR/EIF2AK2, IFIT1/ISG56, IFIT1B, ITIT2, IFIT3, and IFIT5 
were significantly up-regulated at both 6 and 10 dpi. PKR/EIF2AK2 is induced by IFN-β 
and activated by dsRNA (Der et al., 1998). Once activated, PKR inhibits all protein 
synthesis in the cell via phosphorylation of the translation initiation factor eIF2α. IFIT1/
ISG56, IFIT1B, ITIT2, IFIT3, and IFIT5 are functionally related, containing IFN-stimulated 
response elements (ISREs) for gene transcription after IFN activation and can also be 
triggered by PAMPs before the induction of type I IFNs (Diamond and Farzan, 2013). A 
recent study demonstrated that IFIT1 and IFIT3 possess antiviral functions (Guo et al., 
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2000). IFIT1 can inhibit translation by binding to eukaryotic initiation factor 3 (eIF3) and 
also prevents viral replication by targeting viral 5′ triphosphate-RNAs (PPP-RNA) for 
destruction (Pichlmair et al., 2011). To escape the inhibition of IFIT1, influenza virus has 
evolved to express large quantities of short ppp-RNA to avoid restriction (Umbach et al., 
2010). It will be interesting to investigate whether HIV and SIV possess a similar 
mechanism to escape inhibition by IFIT proteins; 8) Blocking of Gag trafficking. TRIM22, 
which can inhibit HIV-1 replication by blocking intracellular trafficking of HIV-1 Gag to 
the cell surface, was up-regulated (Barr et al., 2008); 9) Blocking of virus assembly. USP18 
and HERC5 were significantly up-regulated. HERC5 is the major enzyme mediating the 
conjugation of ISG15 to more than 100 proteins in IFN-stimulated cells. A recent study 
showed that human HERC5 arrests HIV-1 assembly at the plasma membrane via 
conjugation of ISG15 to Gag protein (Woods et al., 2011). After SIV infection, the HERC5 
gene was up-regulated 8.8- and 29-fold at 6 dpi and 10 dpi, respectively, which may help the 
host cell contain the release of SIV; 10) Blocking of virus release. Tetherin/BST-2, ISG15, 
and viperin were significantly up-regulated at both 6 and 10 dpi. Tetherin/BST-2 is an IFN-
α-induced protein localized to the cell surface and is critical for the antiretroviral activity of 
type I IFN in vivo (Liberatore and Bieniasz, 2011). Tetherin/BST-2 efficiently inhibits 
retroviral release by trapping virions on the cell surface (Neil et al., 2008). ISG15 gene was 
one of the most up-regulated genes, and expression of ISG15 inhibits the ubiquitination of 
HIV Gag protein and other host proteins, resulting in impaired viral budding from the host 
cell (Okumura et al., 2006). Moreover, ISG15 plays a critical role in the host’s response 
against other viral infections (Lenschow, 2010).
It should be noted that, some of the above discussed viral restriction factors were shown to 
inhibit viruses other than SIV and HIV. Their inhibition mechanisms on SIV and HIV might 
be different, and therefore need to be further studied. As the top up-regulated genes at 6 and 
10dpi, the IFIT protein family members very likely contribute to SIV inhibition. And other 
factors may also have more mechanisms of viral restriction than we currently know, such as 
MX2 gene, which was up-regulated 75-fold 10dpi and was recently shown to inhibit HIV-1 
DNA integration (Liu et al., 2013). It will be interesting to study the kinetics of expression 
levels and patterns of the restriction factors in various cell types to further elucidate 
interactions between host and virus.
Besides the well-studied anti-viral factors, our study also revealed DEGs with similar levels 
of up-regulation as top altered restriction factors, for example IFI44L, IFI6, PLA2G4C, 
USP18, LY6E etc. (Tab. S1). Previous high through-put screening showed that IFI6 inhibits 
yellow fever virus and IFI44L inhibits hepatitis C virus (HCV), whereas LY6E significantly 
enhances yellow fever virus (YFV) infection(Schoggins et al., 2011). And PLA2G4C and 
USP18 were both reported to facilitate HCV replication(Randall et al., 2006; Xu et al., 
2012). While the effects of up-regulated levels of IFI44L and IFI6 on SIV replication in vivo 
need to be further investigated, PLA2G4C, USP18 and LY6E, together with some DEGs 
identified in this study, might represent positive forces from host that facilitate SIV 
replication.
Despite potent antiviral responses presented in rhesus rectal mucosa, SIV still finds ways to 
overcome the restrictions and expand locally and disseminate systemically. The possible 
Lu et al. Page 8
Virology. Author manuscript; available in PMC 2016 March 27.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
mechanisms may be the followings. Firstly, SIV preferentially expresses abundant accessory 
genes during very early rectal infection as revealed by mRNA-seq (Fig. 5). The SIV 
accessory gene products are known to antagonize host intrinsic and innate anti-viral 
molecules. The high levels of accessory gene products (Vif, Vpu, Vpr, Vpx and Nef) 
antagonize the restriction from host cells and facilitate viral replication. SIV Vpx protein 
binds SAMHD1 and recruits the ubiquitin ligase complex, resulting in SAMHD1 
degradation in the proteasome (Blanco-Melo et al., 2012), and also counteracts APOBEC3A 
by inducing its degradation (Berger et al., 2011). Vif binds APOBEC3 proteins and results 
in its degradation in the proteasome (Blanco-Melo et al., 2012). HIV-1 Vpu and SIV Nef 
bind tetherin/BST-2, resulting in its sequestration and degradation (Blanco-Melo et al., 
2012). Vpr and Vif interact with cullin-associated ubiquitin complex and target IRF3 for 
degradation, resulting in the inhibition of IFNβ synthesis (Okumura et al., 2008). Secondly, 
some altered host genes in expression revealed in this study might facilitate SIV replication, 
just like the factors identified to enhance the replication of other viruses (Randall et al., 
2006; Xu et al., 2012), PLA2G4C and USP18 are potential factors in this category. Thirdly, 
the significantly up-regulated genes related to the mucosal proinflammatory responses, 
immune activation and immune cell trafficking may facilitate SIV replication by attracting 
CCR5+ CD4+ T cells to the rectal mucosa(Fig. 2).
Collectively, our study revealed for the first time robust responses in rhesus rectal mucosa 
during very early rectal transmission of SIV, including pattern recognition, complement, 
inflammation, IFN signaling and innate antiviral responses. The DEGs we identified in this 
study include all the previous known anti-HIV factors, and potential HIV-1 restriction factor 
candidates. Furthermore, our study revealed genome-wide SIV expression in vivo in early 
rectal infection. Together, this first comprehensive genome wide study of early host and SIV 
interaction in rectum provides new insights into the mechanism of rectal transmission and 
identifies potential targets for future study to validate and block this route of transmission.
Materials and Methods
Rhesus macaques and rectal SIV inoculation
Thirteen adult male rhesus macaques (Macacca mulatta) of Indian origin housed at 
BIOQUAL, Inc. in accordance with the regulations of the American Association for 
Accreditation of Laboratory Animal Care standards were used in this study. All animals 
were tested negative for HIV-2, SIV, type D retrovirus, and SRV-1 infections. Infectious 
SIVmac251 swarms, provided by Dr. Nancy Miller, were propagated in PBMC of rhesus 
macaques. Ten macaques were intra-rectally inoculated with SIVmac251 (3.1 × 104 
TCID50) and were euthanized at 3 days (3 macaques), 6 days (4 macaques) or 10 days (3 
macaques) post-inoculation. Three macaques without virus inoculation served as uninfected 
controls. Rectal tissues were frozen in liquid nitrogen immediately after dissection and 
stored at -80°C until analysis.
RNA extraction and next-generation sequencing
At necropsy, the anus and rectum were cut open, divided into six strips with 1.5 cm in length 
numbered from anus upward, and the third strip was further cut into 1.5 cm × 0.5 cm pieces 
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for fixation or snap frozen for RNA extraction. For RNA extraction in this study, one or two 
pieces of frozen rectum sample from strip 3 were used depending on yield of RNA 
extracted. Total RNA was extracted according to our previously published protocol (Li et 
al., 2009b). Briefly, rectal tissues were homogenized with a power homogenizer in TRIzol 
(cat #15596-018, Invitrogen) and further purified using the RNeasy Mini Kit (cat #74104, 
Qiagen). RNA quality was verified on a Bioanalyzer 2100 (Agilent, Palo Alto, CA). A total 
of 10 μg RNA from each monkey was used for downstream preparation for deep-
sequencing. mRNA-seq libraries were generated using the Sample Prep Kit (cat 
#FC-122-1001, Illumina Inc.) according to the manufacturer’s instructions. Briefly, mRNAs 
were purified from total RNA using oligo-dT magnetic beads, fragmented, and reverse 
transcribed into cDNAs, which went through an end-repair process followed by ligation to 
adapters. A single DNA fragment was enriched by PCR and used for sequencing on an 
Illumina Genome Analyzer IIx (GA IIx) sequencer at the Genomics Core Research Facility 
(GCRF) at the University of Nebraska-Lincoln (UNL). Each of the 13 samples sequenced 
had approximately 30 million 76-nucleotide single-end reads, and the sequencing results 
passed quality control. The raw data were deposited in the Sequence Read Archive (SRA) of 
the National Center for Biotechnology Information (NCBI) under accession number 
SRX270636.
Transcriptome data Analysis
Reads from each sample were mapped to the rhesus macaque genome (Mmul_051212) and 
SIVmac251 full-length reference sequences using GSNAP program (Wu and Nacu, 2010) 
with default parameters, and the resulting SAM files were converted to BAM files using 
SAMtools (Li et al., 2009a). Integrative Genomics Viewer (IGV) (Thorvaldsdottir et al., 
2013) was used for visualization and mapping quality checking. For rhesus transcriptome 
analysis, Java Picard utilities were used to count the number of reads mapped to each gene 
annotated in the rhesus macaque reference genome. The read count data were then 
statistically analyzed using the DESeq package, which implements an extended negative 
binomial distribution model (Anders and Huber, 2010). Genes with adjusted p-value 
(Benjamini-Hochberg method) lower than 0.05 and a fold change greater than two were 
defined as differentially expressed genes (DEGs), which were further analyzed using IPA 
(Ingenuity Systems, www.ingenuity.com), DAVID (http://david.abcc.ncifcrf.gov/) and 
literature search for gene categorization and pathway activation. To analyze the level of SIV 
mRNA, reads mapped to the SIVmac251 reference sequence were counted base-by-base 
using SAMtools. The count data were normalized based on total reads in each sample, 
averaged and plotted to show the different levels of reads coverage at 6 dpi and 10 dpi.
Immunohistochemical staining and quantitative image analysis
Rectal tissues were dissected from euthanized monkeys and immediately fixed in SafeFix II 
(cat# 23-042-600, Fisher Scientific) and embedded in paraffin. Antibodies against IFITM3 
(1:5,000 dilution; cat# 3776-1, Epitomics Inc.) and MX1 (1:3,000 dilution; cat# ab95926, 
Abcam) were used for Immunohistochemical staining (IHCS) by following procedures 
described previously (Li et al., 2005). The stained slides were digitized using ScanScope 
(Aperio, Vista, CA). For quantitative image analysis, the images of slides were imported 
into ImageScope, and regions of laminar propria were selected using ImageScope drawing 
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tools. IFITM3+ or MX1+ cells were quantified using a positive pixel count algorithm in the 
Spectrum Plus analysis program (version 9.1). The parameters of the algorithm were 
manually tuned to accurately match the IFITM3+ or MX1+ markup image over the 
background DAB stain. Once the parameters were set, the algorithm was applied 
automatically to all images to measure IFITM3+ or MX1+ positive signals by area.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Mucosal responses in rhesus monkeys during early SIV rectal transmission were 
studied
• Rectal mucosal responses were detected as early as 3 days post infection
• More robust responses were mobilized at 6 and 10 days post infection.
• Genes whose expression may contribute to rectal transmission are identified
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Fig. 1. 
Differentially expressed genes/transcripts in rectal mucosae of SIV-infected macaques at 3, 
6 and 10 dpi. (A) Number of up- and down-related genes at each time point as compared 
with uninfected control macaques. (B) Uniquely and commonly altered genes at each time 
point. Up-regulated genes are depicted in red and down-regulated genes in blue.
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Fig. 2. 
Functional categorization of differentially expressed genes in rectal mucosae at 3 (A), 6 (B) 
and 10 dpi (C). Only the top 20 up- and down-regulated genes in metabolisms and 
maintenance categories are listed in (B) and (C). Up-regulated genes are shown in red and 
down-regulated genes in blue.
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Fig. 3. 
Differentially expressed genes related to IFN signaling in rectal mucosae at 6 and 10 dpi. 
IFN-stimulated genes are classified based on their functions. The levels of up-regulation are 
color-coded based on log2 (fold change).
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Fig. 4. 
Expression of MX1 and IFITM3 proteins in rectal mucosa. (A) Representative IHCS of 
MX1 and IFITM3 in uninfected control and SIV-infected rhesus macaques. (B) 
Quantification of MX1 and IFITM3 levels in rectal mucosa of all rhesus macaques in this 
study. Bar=100μm
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Fig. 5. 
Transcriptome analysis of SIV replication in rhesus macaques. Coverage of mRNA-seq 
reads at each position of the SIV genome at 6 dpi and 10 dpi.
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